| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2221 | 2018 |
| An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ... Nature 478 (7368), 197-203, 2011 | 1843 | 2011 |
| Brain tumour cells interconnect to a functional and resistant network M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ... Nature 528 (7580), 93-98, 2015 | 916 | 2015 |
| Lomustine and bevacizumab in progressive glioblastoma W Wick, T Gorlia, M Bendszus, M Taphoorn, F Sahm, I Harting, ... New England Journal of Medicine 377 (20), 1954-1963, 2017 | 888 | 2017 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 823 | 2016 |
| A vaccine targeting mutant IDH1 induces antitumour immunity T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ... Nature 512 (7514), 324-327, 2014 | 762 | 2014 |
| Glutamatergic synaptic input to glioma cells drives brain tumour progression V Venkataramani, DI Tanev, C Strahle, A Studier-Fischer, L Fankhauser, ... Nature 573 (7775), 532-538, 2019 | 716 | 2019 |
| DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis F Sahm, D Schrimpf, D Stichel, DTW Jones, T Hielscher, S Schefzyk, ... The lancet oncology 18 (5), 682-694, 2017 | 704 | 2017 |
| High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ... Blood, The Journal of the American Society of Hematology 120 (13), 2700-2703, 2012 | 678 | 2012 |
| Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody D Capper, M Preusser, A Habel, F Sahm, U Ackermann, G Schindler, ... Acta neuropathologica 122, 11-19, 2011 | 532 | 2011 |
| ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for … DE Reuss, F Sahm, D Schrimpf, B Wiestler, D Capper, C Koelsche, ... Acta neuropathologica 129, 133-146, 2015 | 501 | 2015 |
| cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading DN Louis, P Wesseling, K Aldape, DJ Brat, D Capper, IA Cree, C Eberhart, ... Brain Pathology 30 (4), 844-856, 2020 | 492 | 2020 |
| Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate L Bunse, S Pusch, T Bunse, F Sahm, K Sanghvi, M Friedrich, D Alansary, ... Nature medicine 24 (8), 1192-1203, 2018 | 417 | 2018 |
| Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein L Schweizer, C Koelsche, F Sahm, RM Piro, D Capper, DE Reuss, ... Acta neuropathologica 125, 651-658, 2013 | 385 | 2013 |
| Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience D Capper, D Stichel, F Sahm, DTW Jones, D Schrimpf, M Sill, S Schmid, ... Acta neuropathologica 136, 181-210, 2018 | 381 | 2018 |
| Novel, improved grading system (s) for IDH-mutant astrocytic gliomas M Shirahata, T Ono, D Stichel, D Schrimpf, DE Reuss, F Sahm, ... Acta neuropathologica 136, 153-166, 2018 | 371 | 2018 |
| TERT promoter mutations and risk of recurrence in meningioma F Sahm, D Schrimpf, A Olar, C Koelsche, D Reuss, J Bissel, A Kratz, ... Journal of the National Cancer Institute 108 (5), djv377, 2016 | 355 | 2016 |
| Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study P Kickingereder, F Isensee, I Tursunova, J Petersen, U Neuberger, ... The Lancet Oncology 20 (5), 728-740, 2019 | 351 | 2019 |
| IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO DE Reuss, Y Mamatjan, D Schrimpf, D Capper, V Hovestadt, A Kratz, ... Acta neuropathologica 129, 867-873, 2015 | 344 | 2015 |
| Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma F Sahm, D Reuss, C Koelsche, D Capper, J Schittenhelm, S Heim, ... Acta neuropathologica 128, 551-559, 2014 | 341 | 2014 |
